When should albumin be administered for large-volume paracentesis and for treatment of spontaneous bacterial peritonitis?

Albumin Administration in Large-Volume Paracentesis and Spontaneous Bacterial Peritonitis

Direct Answer

Administer intravenous albumin at 6-8 g per liter of ascites removed when performing large-volume paracentesis (>5 L), and give 1.5 g/kg on day 1 plus 1.0 g/kg on day 3 for all patients with spontaneous bacterial peritonitis (SBP) receiving antibiotics. 1, 2

---

Large-Volume Paracentesis (LVP)

When to Give Albumin

• Mandatory for paracentesis >5 L - This threshold is where postparacentesis circulatory dysfunction (PPCD) risk becomes clinically significant 1, 2
• Consider limiting single sessions to <8 L - Risk of PPCD increases substantially beyond 8 L removed 1
• Paracentesis ≤5 L does not require albumin - Smaller volumes don't cause significant hemodynamic changes 1

Dosing for LVP

Standard dose: 6-8 g of albumin per liter of ascites removed 1, 2

Practical dosing examples from guidelines 1:

• After 5 L removed: ~40 g albumin
• After 8 L removed: ~64 g albumin

Special population - ACLF patients: Give 6-8 g/L regardless of volume removed (even if <5 L) 2

Evidence Supporting LVP Albumin Use

The 2021 AASLD guidelines establish LVP as first-line treatment for refractory ascites, with albumin preventing PPCD - a syndrome causing renal impairment, hepatorenal syndrome, dilutional hyponatremia, hepatic encephalopathy, and death 1. A key RCT showed that daily 5-L paracenteses without albumin caused AKI in 21% of patients, while zero patients receiving albumin developed AKI 2. Recent real-world data from 56,941 outpatient paracentesis procedures demonstrated albumin reduced AKI-related hospitalizations (OR 0.66), with greater benefit in patients with lower eGFR 3.

Important Caveats for LVP

• Albumin is hyperoncotic - Must give with or followed by crystalloid fluids in dehydrated patients 4
• Monitor for fluid overload - Particularly in patients with cardiac or renal dysfunction 2, 4
• Higher doses may be beneficial - One study using 9.0 ± 2.5 g/L (higher than standard) showed better renal function preservation over 2 years despite 40% developing PPCD 1

---

Spontaneous Bacterial Peritonitis (SBP)

When to Give Albumin

Give albumin to ALL patients with SBP receiving antibiotics 2

The 2024 AGA guidelines are clear: albumin should be considered in all SBP patients, with particular emphasis on high-risk subgroups 2.

Dosing for SBP

Standard regimen: 1.5 g/kg on day 1 and 1.0 g/kg on day 3 2

This is the evidence-based dose from the landmark RCT that demonstrated mortality benefit 2.

Alternative lower-dose approach: Some data suggest 10 g/day for days 1-3 may be effective, though this is not standard practice 2

Evidence Supporting SBP Albumin Use

The pivotal multicenter RCT of 105 SBP patients showed albumin plus antibiotics versus antibiotics alone resulted in 2:

• AKI reduction: 10% vs 33% (P<0.001)
• Mortality reduction: 10% vs 29% (P<0.001)

Two meta-analyses confirmed these benefits 2. The most recent 2026 propensity-matched cohort study (n=1,230 per group) demonstrated early albumin administration was associated with 5:

• Reduced all-cause mortality (RR 0.620 at 5 days, RR 0.770 at 90 days)
• Reduced AKI (RR 0.654 at 5 days)
• Reduced hepatorenal syndrome-AKI (RR 0.598 at 5 days)
• Reduced vasopressor requirement (RR 0.633 at 5 days)
• Reduced need for renal replacement therapy (RR 0.533 at 5 days)

High-Risk Patients Who Benefit Most

Prioritize albumin in patients with 2:

• Serum bilirubin >4 mg/dL
• Baseline creatinine >1.0 mg/dL
• Blood urea nitrogen >30 mg/dL

Subgroup analysis showed these patients are at highest risk of AKI and derive the greatest benefit from albumin 2.

Mechanism in SBP

AKI in SBP results from systemic inflammation causing vasodilation and decreased effective arterial blood volume - albumin counteracts this through volume expansion and anti-inflammatory effects 2.

---

Critical Pitfalls to Avoid

Do NOT Give Albumin For:

1. Infections other than SBP - Three RCTs and meta-analysis showed albumin does NOT reduce AKI or mortality in non-SBP infections and was associated with MORE pulmonary edema 2

2. Chronic conditions as protein supplementation 4:

   • Chronic nephrosis (albumin is promptly excreted)
   • Chronic cirrhosis without acute indication
   • Malabsorption or protein-losing enteropathies
   • Malnutrition

3. Small-volume paracentesis ≤5 L (unless patient has ACLF) 1, 2

Monitoring Requirements

• Watch for circulatory overload - Especially with 25% albumin formulations 4
• Rapid blood pressure rise may unmask previously non-bleeding vessels 4
• Fluid overload complications include pulmonary edema, pleural effusion 2

---

Practical Implementation

For LVP:

1. Determine volume to be removed
2. If >5 L planned: calculate 6-8 g albumin per liter
3. Administer albumin during or immediately after paracentesis
4. Ensure adequate hydration with crystalloids if using 25% albumin

For SBP:

1. Diagnose SBP (ascitic PMN >250/mm³)
2. Start antibiotics immediately
3. Give albumin 1.5 g/kg on day 1 (within 6 hours of diagnosis ideally)
4. Give albumin 1.0 g/kg on day 3
5. Monitor for fluid overload, especially in patients with cardiac/renal comorbidities

Timing Matters

Real-world data shows albumin within 24 hours of admission for SBP was associated with 72% higher hazard of hospital discharge (shorter LOS) 6. Early administration appears critical for optimal outcomes 5.

---

Cost Considerations

Recent data suggests capped albumin dosing at 100 g for SBP (versus full weight-based dosing >100 g) showed no significant difference in AKI rates (10% vs 6%, P=0.381), suggesting potential cost savings without compromising outcomes in select patients 7. However, this requires validation before routine implementation, and standard weight-based dosing remains the guideline recommendation 2.